The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient value investors.
Pfizer Inc.’s stock dipped 2.5% Thursday as the company’s battle with activist shareholder Starboard Value heated up, after two former executives for the pharma giant said they would not ...
Pfizer CEO Albert Bourla is in a tough spot as activist investor Starboard Value continues to call for a change in the ...